Infections associated with malignancy: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "== Bacteria == * Bacteremia with many bacteria is associated with new diagnosis of colorectal cancer within 1 year * Clostridium species (OR 17) and in particular Clostridium septicum (OR 17) * Gemella morbillorum (OR 15) * Fusobacterium nucleatum (OR 5 to 7) * Streptococcus bovis group (OR 9), mostly from * Streptococcus gallolyticus (OR 6) * Bacteroides species (OR 6), including Bacteroides fragilis (OR 4) and Bacteroides ovatus (O..." |
mNo edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
== Viruses == |
|||
* [[EBV]]: lymphoma, nasopharyngeal cancer |
|||
* [[Hepatitis B]]: [[hepatocellular carcinoma]] |
|||
* [[Hepatitis C]]: [[hepatocellular carcinoma]] |
|||
* [[HHV-8]]: [[Kaposi sarcoma]] |
|||
* [[Human immunodeficiency virus|HIV-1]]: [[Kaposi sarcoma]], [[lymphoma]], [[cervical cancer]], [[anal cancer]] |
|||
* [[HPV]]: vaginal, vulvar, penile, and head-and-neck cancer |
|||
* [[HLTV|HLTV-1]]: T cell cancers |
|||
== Bacteria == |
== Bacteria == |
||
* [[Helicobacter pylori]]: stomach cancer, esophageal cancer, gastric mucosa-associated lymphoid tissue lymphoma |
|||
* Bacteremia with many bacteria is associated with new diagnosis of colorectal cancer within 1 year |
* Bacteremia with many bacteria is associated with new diagnosis of '''colorectal cancer''' within 1 year[[CiteRef::kwong2018as]][[CiteRef::justesen2022ba]] |
||
* [[Clostridium]] species (OR 17) and in particular [[Clostridium septicum]] (OR 17) |
** [[Clostridium]] species (OR 17) and in particular [[Clostridium septicum]] (OR 17) and [[Clostridium perfringens]] (OR 2) |
||
* [[Gemella morbillorum]] (OR 15) |
|||
* [[ |
** [[Gemella morbillorum]] (OR 15) |
||
* [[ |
** [[Fusobacterium nucleatum]] (OR 5 to 7) |
||
* [[Streptococcus gallolyticus]] (OR 6) |
** [[Streptococcus bovis group]] (OR 9), mostly from [[Streptococcus gallolyticus]] (OR 6) subspecies ''gallolyticus'' |
||
* [[Bacteroides]] species (OR 6), including [[Bacteroides fragilis]] (OR 4) and [[Bacteroides ovatus]] (OR 20) |
** [[Bacteroides]] species (OR 6), including [[Bacteroides fragilis]] (OR 4) and [[Bacteroides ovatus]] (OR 20) |
||
* Gram-positive anaerobic cocci (OR 11), including [[Peptostreptococcus]] species (OR 3) |
** Gram-positive anaerobic cocci (OR 11), including [[Peptostreptococcus]] species (OR 3) |
||
== Parasites == |
|||
* Liver fluke ([[Opisthorchis viverrini]] and [[Clonorchis sinensis]]): [[cholangiocarcinoma]] and [[hepatocellular carcinoma]] |
|||
* [[Clostridium perfringens]] (OR 2) |
|||
* [[Schistosoma haematobium]]: [[bladder cancer]] |
|||
[[Category:Oncology]] |
[[Category:Oncology]] |
||
Latest revision as of 18:14, 19 September 2024
Viruses
- EBV: lymphoma, nasopharyngeal cancer
- Hepatitis B: hepatocellular carcinoma
- Hepatitis C: hepatocellular carcinoma
- HHV-8: Kaposi sarcoma
- HIV-1: Kaposi sarcoma, lymphoma, cervical cancer, anal cancer
- HPV: vaginal, vulvar, penile, and head-and-neck cancer
- HLTV-1: T cell cancers
Bacteria
- Helicobacter pylori: stomach cancer, esophageal cancer, gastric mucosa-associated lymphoid tissue lymphoma
- Bacteremia with many bacteria is associated with new diagnosis of colorectal cancer within 1 year12
- Clostridium species (OR 17) and in particular Clostridium septicum (OR 17) and Clostridium perfringens (OR 2)
- Gemella morbillorum (OR 15)
- Fusobacterium nucleatum (OR 5 to 7)
- Streptococcus bovis group (OR 9), mostly from Streptococcus gallolyticus (OR 6) subspecies gallolyticus
- Bacteroides species (OR 6), including Bacteroides fragilis (OR 4) and Bacteroides ovatus (OR 20)
- Gram-positive anaerobic cocci (OR 11), including Peptostreptococcus species (OR 3)
Parasites
References
- ^ Ulrik S Justesen, Stig L Nielsen, Thøger G Jensen, Ram B Dessau, Jens K Møller, John E Coia, Steen L Andersen, Court Pedersen, Kim O Gradel. Bacteremia With Anaerobic Bacteria and Association With Colorectal Cancer: A Population-based Cohort Study. Clinical Infectious Diseases. 2022;75(10):1747-1753. doi:10.1093/cid/ciac259.
